Presentation TVT 2022 Optimal antithrombotic regimen after transcatheter aortic valve replacement (TAVR): long term follow-up study Presenter: Melissa Moey June 09, 2022 REGISTER for free or LOG IN to view this content Structural Heart TVT 2022 TAVR Up Next Presentation TVT 2022 Outcomes of Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valves Presenter: Sarah Yousef June 09, 2022 More slides + Presentation TVT 2022 Safety and Efficacy of Transcatheter Aortic Valve Replacement in Patients with Bicuspid versus Tricuspid Aortic Valve Stenosis: A Metanalysis Presenter: Yasser Radwan June 09, 2022 Presentation TVT 2022 Quantification of Mitral Annular Calcification per Guerrero Criteria and Impact on Post-TAVR Outcomes Presenter: Omar Sheikh June 09, 2022 We Recommend Disclosures NULL
Presentation TVT 2022 Outcomes of Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valves Presenter: Sarah Yousef June 09, 2022
Presentation TVT 2022 Safety and Efficacy of Transcatheter Aortic Valve Replacement in Patients with Bicuspid versus Tricuspid Aortic Valve Stenosis: A Metanalysis Presenter: Yasser Radwan June 09, 2022
Presentation TVT 2022 Quantification of Mitral Annular Calcification per Guerrero Criteria and Impact on Post-TAVR Outcomes Presenter: Omar Sheikh June 09, 2022